BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24874401)

  • 1. Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.
    Rivoire BL; Groathouse NA; TerLouw S; Neupane KD; Ranjit C; Sapkota BR; Khadge S; Kunwar CB; Macdonald M; Hawksworth R; Thapa MB; Hagge DA; Tibbals M; Smith C; Dube T; She D; Wolff M; Zhou E; Makhene M; Mason R; Sizemore C; Brennan PJ
    PLoS Negl Trop Dis; 2014; 8(5):e2811. PubMed ID: 24874401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
    Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
    BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of producing skin test antigens with minimal resources suitable for human application against a neglected tropical disease; leprosy.
    Rivoire BL; TerLouw S; Groathouse NA; Brennan PJ
    PLoS Negl Trop Dis; 2014; 8(5):e2791. PubMed ID: 24874086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.
    Weir RE; Brennan PJ; Butlin CR; Dockrell HM
    Clin Exp Immunol; 1999 May; 116(2):263-9. PubMed ID: 10337017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
    Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
    Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy.
    Singh I; Yadav AR; Mohanty KK; Katoch K; Bisht D; Sharma P; Sharma B; Gupta UD; Sengupta U
    Cell Immunol; 2012; 278(1-2):63-75. PubMed ID: 23121977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity to Mycobacterium leprae soluble antigens as a test for infection with the leprosy bacillus.
    Sterne JA; Fine PE; Pönnighaus JM; Rees RJ; Chavula D
    Int J Epidemiol; 1998 Aug; 27(4):713-21. PubMed ID: 9758130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
    Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection.
    Arend SM; Franken WP; Aggerbeck H; Prins C; van Dissel JT; Thierry-Carstensen B; Tingskov PN; Weldingh K; Andersen P
    Tuberculosis (Edinb); 2008 May; 88(3):249-61. PubMed ID: 18155963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin test development in leprosy: progress with first-generation skin test antigens, and an approach to the second generation.
    Brennan PJ
    Lepr Rev; 2000 Dec; 71 Suppl():S50-4. PubMed ID: 11201887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy.
    Sampaio LH; Sousa AL; Barcelos MC; Reed SG; Stefani MM; Duthie MS
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1443-51. PubMed ID: 22076550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences with Mycobacterium leprae soluble antigens in a leprosy endemic population.
    Gupte MD; Anantharaman DS; Nagaraju B; Kannan S; Vallishayee RS
    Lepr Rev; 1990 Jun; 61(2):132-44. PubMed ID: 2198413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
    Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience and lessons from the use of lepromin and Mycobacterium leprae-specific serology.
    Sengupta U
    Lepr Rev; 2000 Dec; 71 Suppl():S63-6. PubMed ID: 11201890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population.
    Manandhar R; LeMaster JW; Butlin CR; Brennan PJ; Roche PW
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):40-8. PubMed ID: 10834068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.